Lv1
72 积分 2026-01-16 加入
GC-CDSS: Personalized gastric cancer treatment recommendations system based on knowledge graph
19天前
已完结
Recent advances in tumour microenvironment impact immunotherapy resistance in gastric cancer
20天前
已完结
The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming
23天前
已完结
Tumor microenvironment in gastric cancer immune tolerance and its therapeutic relevance in immunomodulation (Review)
23天前
已完结
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
24天前
已完结
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
24天前
已完结
An evaluation of pembrolizumab with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)
24天前
已完结
1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
24天前
已关闭
Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype
24天前
已完结
Precision oncology in gastric cancer: navigating molecular subtypes, therapeutic targets, and future horizons
24天前
已完结
皖公网安备34019202002308
